BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 8, 2015
View Archived Issues
Constellation Pharmaceuticals tests EZH2 inhibitor in patients with B-cell lymphoma
Read More
German scientists report development of bi- or multispecific antibodies
Read More
rHuCat-L shows promising results for the treatment of cellulite
Read More
State University of New York patents novel dendrimer-drug conjugates
Read More
Ocular Therapeutix reports results from second phase III trial of dexamethasone punctal plug
Read More
New OX2R antagonist shows potential for the treatment of insomnia
Read More
sGC activators prevent progression of diabetic nephropathy
Read More
Nabriva Therapeutics raises funds to advance new class of antibiotic
Read More
Repros' enclomiphene eligible for new active substance status
Read More
PCI Biotech begins preclinical research collaboration in siRNA therapeutics
Read More
Scripps receives grant to develop treatments for intellectual disability, autism, epilepsy
Read More
BIND Therapeutics extends global collaboration with Pfizer to develop multiple Accurins
Read More
Carna Biosciences patents novel BTK inhibitors
Read More
Karyopharm Therapeutics discloses PAK inhibitors
Read More
Alios BioPharma develops new antivirals
Read More
GlaxoSmithKline describes novel inhibitors of RIP-1 and RIP-2 kinases
Read More
Targeting IRS proteins presented as a new approach for prostate cancer therapy
Read More
Sanofi Pasteur to use VBI Vaccines' lipid particle vaccine technology
Read More
GlaxoSmithKline's SARM for muscle wasting diseases
Read More
Gilead Sciences files NDA for emtricitabine/tenofovir alafenamide combination for HIV infection
Read More
Analysis of HLA genes links genotypes to risk of atherosclerosis in patients with psoriasis
Read More
TaxusCardium licenses ASEAN and Latin American rights to Generx to Dr Reddy's
Read More
Celtaxsys to start phase II trial of oral CTX-4430 in acne vulgaris
Read More
AmorChem invests in Canada's Personalized Cancer Immunotherapy Program
Read More
Cytori Therapeutics' ECCS-50 receives E.U. orphan drug designation for scleroderma
Read More